Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Melmon

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
California Medicine|January 1, 1971
The clinician in medical investigation--the carcinoid spectrum as an exampleK L Melmon
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|January 1, 1984
Will the sighted physician see?K L Melmon
Journal of Clinical Epidemiology|January 1, 1989
Adverse effects of drug banningK L Melmon
The New England Journal of Medicine|June 17, 1971
Preventable drug reactions--causes and curesK L Melmon
California Medicine|September 1, 1972
Catecholamines. A product of clinical and basic scienceK L Melmon
Clinical Research|August 9, 1982
Changing patterns of biomedical research funding: the impact on the clinical investigatorK L Melmon
Clinical Pharmacology and Therapeutics|April 1, 1986
The public need for clinical pharmacology in the United StatesK L Melmon
Clinical Pharmacology and Therapeutics|August 1, 1976
Editorial: The clinical pharmacologist and scientifically unsound regulations for drug developmentK L Melmon
Cardiovascular Clinics|January 1, 1974
The clinical pharmacology of commonly used antihypertensive drugsK L Melmon
The Journal of Clinical Investigation|July 1, 1979
A society without an obvious future: can elitism help? Presidential address before the 71st annual meeting of the American Society for Clinical Investigation, Washington, D.C., 5 May 1979K L Melmon
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
California Medicine|January 1, 1971
The clinician in medical investigation--the carcinoid spectrum as an exampleK L Melmon
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|January 1, 1984
Will the sighted physician see?K L Melmon
Journal of Clinical Epidemiology|January 1, 1989
Adverse effects of drug banningK L Melmon
The New England Journal of Medicine|June 17, 1971
Preventable drug reactions--causes and curesK L Melmon
California Medicine|September 1, 1972
Catecholamines. A product of clinical and basic scienceK L Melmon
Clinical Research|August 9, 1982
Changing patterns of biomedical research funding: the impact on the clinical investigatorK L Melmon
Clinical Pharmacology and Therapeutics|April 1, 1986
The public need for clinical pharmacology in the United StatesK L Melmon
Clinical Pharmacology and Therapeutics|August 1, 1976
Editorial: The clinical pharmacologist and scientifically unsound regulations for drug developmentK L Melmon
Cardiovascular Clinics|January 1, 1974
The clinical pharmacology of commonly used antihypertensive drugsK L Melmon
The Journal of Clinical Investigation|July 1, 1979
A society without an obvious future: can elitism help? Presidential address before the 71st annual meeting of the American Society for Clinical Investigation, Washington, D.C., 5 May 1979K L Melmon
Pageof 17